$INTS – Weekly Setup | High-Risk / High-Reward Swing Play
INTS remains heavily depressed after a long downtrend, but the recent weekly structure is starting to show signs of stabilization and potential accumulation.
This setup presents a very aggressive risk–reward, with substantial upside potential if price can hold above the recent support area.
📌 Entry
≈ 0.47 USD
📉 Stop-Loss
≈ 0.3445 USD
Below the most recent pivot — structure would be invalid if this level breaks.
🎯 Take-Profit (Main Target)
≈ 3.76 USD
Targeting prior imbalance + old liquidity zone around 3–4 USD.
📊 Risk / Reward
RR ≈ 1 : 6.8
Potential upside of over 680% if the target is reached.
📎 Technical Breakdown
Massive weekly selloff followed by compression and a strong impulse candle.
Potential CHoCH emerging.
Large liquidity pool above still untouched.
Highly speculative microcap setup; extremely volatile.
⚠️ Note
High-risk play. Valid only while price holds above 0.34 USD.
This setup presents a very aggressive risk–reward, with substantial upside potential if price can hold above the recent support area.
📌 Entry
≈ 0.47 USD
📉 Stop-Loss
≈ 0.3445 USD
Below the most recent pivot — structure would be invalid if this level breaks.
🎯 Take-Profit (Main Target)
≈ 3.76 USD
Targeting prior imbalance + old liquidity zone around 3–4 USD.
📊 Risk / Reward
RR ≈ 1 : 6.8
Potential upside of over 680% if the target is reached.
📎 Technical Breakdown
Massive weekly selloff followed by compression and a strong impulse candle.
Potential CHoCH emerging.
Large liquidity pool above still untouched.
Highly speculative microcap setup; extremely volatile.
⚠️ Note
High-risk play. Valid only while price holds above 0.34 USD.
Trade aktif
Profit of 7%, not bad. Let´s see what´s happening next week, this type of Pharma stocks can be violent.Catatan
added some more here (100%) , total avg price $9.42 . Same TP´s.
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi ini tidak dimaksudkan, dan bukan merupakan, saran atau rekomendasi keuangan, investasi, trading, atau jenis lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Ketentuan Penggunaan.